Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid response in allergic respiratory and autoimmune inflammatory diseases
jRCT1090220251Completed
- Sponsor
- Division of Pulmonary, Allergy, and Critical Care Medicine, Penn State College of Medicine
- Start
- Jun 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial of corticosteroids in inhalant allergy, rheumatism and autoimmune inflammatory diseases, sponsored by Division of Pulmonary, Allergy, and Critical Care Medicine, Penn State College of Medicine. Primary endpoint: Steroid use to control disease activity. Started Jun 2016; status: completed.
02
Drugs
corticosteroids
03
Conditions
inhalant allergyrheumatismautoimmune inflammatory diseases
Beyond the preview
Go deeper on jRCT1090220251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220251.